BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38390549)

  • 1. Role of
    Moulika JS; Kalawat T; Manthri RG; Hulikal N; Kadiyala S; Bhargavi D; Prayaga AK
    Indian J Nucl Med; 2023; 38(4):354-361. PubMed ID: 38390549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer.
    Trehan R; Seam RK; Gupta MK; Sood A; Dimri K; Mahajan R
    World J Nucl Med; 2014 Sep; 13(3):163-9. PubMed ID: 25538487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
    Evangelista L; Cervino AR; Michieletto S; Saibene T; Orvieto E; Bozza F; Ghiotto C
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):205-215. PubMed ID: 25501326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Mittal BR; Singh RK; Kumari S; Manohar K; Bhattacharya A; Singh G
    Indian J Nucl Med; 2012 Oct; 27(4):221-5. PubMed ID: 24019650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
    Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
    Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Drucker MJ; Livingston RB
    Cancer; 1999 Jun; 85(11):2410-23. PubMed ID: 10357412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
    Listewnik MH; Birkenfeld B; Foszczyńska-Kłoda M; Listewnik MJ; Piwowarska-Bilska H; Zorga P
    Ann Acad Med Stetin; 2011; 57(1):73-8. PubMed ID: 22593995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
    Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer.
    Yoon JH; Bom HS; Song HC; Lee JH; Jaegal YJ
    Clin Nucl Med; 1999 May; 24(5):314-8. PubMed ID: 10232467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.
    Cayre A; Cachin F; Maublant J; Mestas D; Feillel V; Ferrière JP; Kwiaktowski F; Chevillard S; Finat-Duclos F; Verrelle P; Penault-Llorca F
    Int J Oncol; 2002 May; 20(5):1049-55. PubMed ID: 11956603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report.
    Grosso M; Imran MB; Volterrani D; Roncella M; Abufalgha K; Grassetto G; Al-Nahhas A; Rubello D; Mariani G
    Nucl Med Rev Cent East Eur; 2008; 11(2):70-2. PubMed ID: 19585458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Cancer Lett; 2000 May; 153(1-2):95-100. PubMed ID: 10779636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Guo C; Zhang C; Liu J; Tong L; Huang G
    Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
    Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
    Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.